Mizuho Upgrades Sabra Health Care REIT (SBRA) to Buy

Mizuho upgraded shares of Sabra Health Care REIT (NASDAQ:SBRA) from a neutral rating to a buy rating in a report released on Wednesday, March 14th, MarketBeat Ratings reports. They currently have $24.00 target price on the real estate investment trust’s stock.

Other analysts have also issued research reports about the company. ValuEngine lowered Sabra Health Care REIT from a buy rating to a hold rating in a research note on Friday, February 2nd. SunTrust Banks set a $22.00 target price on Sabra Health Care REIT and gave the stock a buy rating in a research note on Monday, January 22nd. BidaskClub upgraded Sabra Health Care REIT from a strong sell rating to a sell rating in a research note on Thursday, March 8th. Raymond James Financial reiterated a hold rating on shares of Sabra Health Care REIT in a research note on Wednesday, December 13th. Finally, Zacks Investment Research downgraded Sabra Health Care REIT from a hold rating to a sell rating in a research report on Wednesday, January 17th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the company’s stock. Sabra Health Care REIT presently has an average rating of Hold and a consensus target price of $23.45.

How to Become a New Pot Stock Millionaire

NASDAQ SBRA traded down $0.07 on Wednesday, reaching $17.70. The company had a trading volume of 1,326,293 shares, compared to its average volume of 1,744,347. The company has a market capitalization of $3,155.13, a PE ratio of 7.28, a P/E/G ratio of 2.32 and a beta of 0.65. The company has a current ratio of 6.85, a quick ratio of 6.85 and a debt-to-equity ratio of 0.99. Sabra Health Care REIT has a 52 week low of $15.77 and a 52 week high of $29.10.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its earnings results on Wednesday, February 21st. The real estate investment trust reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.27. The firm had revenue of $166.47 million during the quarter, compared to analysts’ expectations of $158.82 million. Sabra Health Care REIT had a return on equity of 7.19% and a net margin of 39.04%. sell-side analysts predict that Sabra Health Care REIT will post 2.5 earnings per share for the current fiscal year.

Several hedge funds have recently modified their holdings of SBRA. Bank of New York Mellon Corp boosted its holdings in shares of Sabra Health Care REIT by 294.2% during the 3rd quarter. Bank of New York Mellon Corp now owns 4,721,303 shares of the real estate investment trust’s stock valued at $103,586,000 after acquiring an additional 3,523,631 shares in the last quarter. BlackRock Inc. boosted its holdings in shares of Sabra Health Care REIT by 7.0% during the 4th quarter. BlackRock Inc. now owns 25,569,768 shares of the real estate investment trust’s stock valued at $479,945,000 after acquiring an additional 1,673,758 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Sabra Health Care REIT by 151.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,405,450 shares of the real estate investment trust’s stock valued at $52,774,000 after acquiring an additional 1,450,287 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Sabra Health Care REIT by 5,107.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 893,243 shares of the real estate investment trust’s stock valued at $19,348,000 after acquiring an additional 876,089 shares in the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. boosted its holdings in shares of Sabra Health Care REIT by 7,005.3% during the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 875,014 shares of the real estate investment trust’s stock valued at $19,198,000 after acquiring an additional 862,699 shares in the last quarter. 88.88% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Mizuho Upgrades Sabra Health Care REIT (SBRA) to Buy” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/08/sabra-health-care-reit-sbra-upgraded-at-mizuho.html.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply